study will include the following:
* sex
* age
* BMI
* ethnicity
* age diagnosed with Myeloproliferative disease
* clinical manifestations of the myeloproliferative disease
* JAK2 mutation
* known hematological complications
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\) consenting patients diagnosed with a myeloproliferative disease
You may not be if
1\) Refusal to have an echocardiogram or answer the St. George respiratory questionnaire
Clareo Health | A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
